Cell Reports (Dec 2016)

Blood Stage Malaria Disrupts Humoral Immunity to the Pre-erythrocytic Stage Circumsporozoite Protein

  • Gladys J. Keitany,
  • Karen S. Kim,
  • Akshay T. Krishnamurty,
  • Brian D. Hondowicz,
  • William O. Hahn,
  • Nicholas Dambrauskas,
  • D. Noah Sather,
  • Ashley M. Vaughan,
  • Stefan H.I. Kappe,
  • Marion Pepper

DOI
https://doi.org/10.1016/j.celrep.2016.11.060
Journal volume & issue
Vol. 17, no. 12
pp. 3193 – 3205

Abstract

Read online

Many current malaria vaccines target the pre-erythrocytic stage of infection in the liver. However, in malaria-endemic regions, increased blood stage exposure is associated with decreased vaccine efficacy, thereby challenging current vaccine efforts. We hypothesized that pre-erythrocytic humoral immunity is directly disrupted by blood stage infection. To investigate this possibility, we used Plasmodium-antigen tetramers to analyze B cells after infection with either late liver stage arresting parasites or wild-type parasites that progress to the blood stage. Our data demonstrate that immunoglobulin G (IgG) antibodies against the pre-erythrocytic antigen, circumsporozoite protein (CSP), are generated only in response to the attenuated, but not the wild-type, infection. Further analyses revealed that blood stage malaria inhibits CSP-specific germinal center B cell differentiation and modulates chemokine expression. This results in aberrant memory formation and the loss of a rapid secondary B cell response. These data highlight how immunization with attenuated parasites may drive optimal immunity to malaria.

Keywords